DR. NURI ILKER AKKUS, M.D.

Plain English
This study looked at the genetic causes of developmental delay/intellectual disability (DD/ID) and epilepsy in children by using a technique called whole-exome sequencing (WES). Researchers analyzed data from 65 pediatric patients and found that 31% had identifiable genetic variants linked to these conditions, including a new variant related to BCL11A in a Turkish patient. These findings are important because they expand our understanding of the genetic factors involved in DD/ID and epilepsy, potentially leading to better diagnosis and treatment options. Who this helps: This helps patients with developmental delays and epilepsy, along with their families and healthcare providers.

Plain English
This study looked at genetic factors that might cause repeated miscarriages, focusing on specific genes in a group of Turkish women. They found that women with a particular genetic marker called the GSTT1 null genotype had a higher risk of recurrent pregnancy loss, with a statistical significance noted (X=4.74; p=0.029). This research is important because it helps identify genetic risks that could assist in understanding why some women experience multiple miscarriages. Who this helps: This helps women who have experienced recurrent pregnancy loss and their doctors.

Plain English
This study looked at how well chromosomal microarray analysis works for identifying genetic causes of developmental delays, intellectual disabilities, autism, and multiple birth defects in Turkish patients. Out of 1,227 patients tested, 135 had identifiable genetic variations, with 11% finding specific copy number variants linked to their conditions. Notably, 77 of these patients (57%) were diagnosed with known genetic syndromes. This research is important because it shows how effective this genetic testing can be in understanding and diagnosing complex developmental issues, helping to guide better patient care. Who this helps: This helps patients with unexplained developmental issues and their families by providing clearer diagnoses and potential treatments.

Plain English
This study looked at the genetic mutations in the BRCA1 and BRCA2 genes among 2,168 people in Turkey who either had cancer or were at high risk for cancers related to these genes. Researchers found a total of 68 different mutations in BRCA1 and 157 in BRCA2, including 22 new mutations. Understanding these mutations is crucial for better cancer prevention and treatment strategies, especially tailored to the Turkish population. Who this helps: This research benefits patients with BRCA-related cancers and their doctors by providing critical information for managing their health.

Plain English
The study looked at Smith-Magenis Syndrome (SMS), a genetic disorder that causes mental challenges and behavioral issues. Researchers examined three patients with SMS and found that all had a specific deletion of 3.4 million base pairs on chromosome 17, which impacts a gene crucial for the condition. This is important because understanding the genetic changes in SMS can help improve diagnosis and treatment for those affected. Who this helps: Patients with Smith-Magenis Syndrome and their families.

Plain English
This study looked at the levels of hydrogen sulfide, a substance that can affect heart health, in different groups of people with and without cardiovascular disease (CVD). Researchers found that Caucasian females with CVD had lower levels of a specific form of sulfur compared to those without the disease, while Caucasian males with CVD had lower levels of another type. Overall, African Americans had significantly lower sulfur levels than Caucasians, but gender differences weren't observed in this group. The results suggest that measuring hydrogen sulfide levels could help identify those at risk for heart disease, particularly among different ethnic and gender groups. Who this helps: This helps patients at risk for cardiovascular disease and their doctors.

Plain English
This study looked at the long-term effects of using sirolimus-eluting stents, specifically the Cypher brand, in patients with coronary artery disease. Out of 207 patients, only 9.7% experienced problems with the stent over an average follow-up of about two years, with 5.3% needing further procedures like angioplasty. These results show that Cypher stents have a high success rate and lead to good outcomes for patients needing treatment for blocked heart arteries. Who this helps: This benefits patients with coronary artery disease who require stent placement.

Plain English
This study examined the longer-term effects of using paclitaxel-eluting stents (Taxus) in patients with coronary artery disease. Out of 151 patients who received the stents, only 1.3% had a heart attack afterward, and 3 patients experienced recurring chest pain due to the re-narrowing of the arteries. Overall, the study found that Taxus stents are very effective and safe, leading to positive long-lasting results for patients. Who this helps: Patients with coronary artery disease.

Plain English
This study looked at patients with slow coronary flow (SCF), which is when blood moves slowly through the heart's arteries without blockages. Researchers found that the blood pressure in these arteries (measured using a method called fractional flow reserve or FFR) was significantly lower in these patients, averaging 0.83 compared to the normal level of 1.0. The results showed a connection between slow blood flow and increased artery thickening due to atherosclerosis, which is the buildup of plaque in the arteries. Who this helps: This information helps doctors understand and treat patients with slow coronary flow and related heart conditions.

Plain English
This study looked at how a procedure called right atrial pacing affects certain blood markers in patients with a condition known as myocardial bridging, where a coronary artery is compressed. Researchers found that after the pacing, a harmful substance called endothelin-1 increased in the blood of these patients, going from an average of 5.77 to 11.32 pg/ml, while it did not change in healthy individuals. This matters because it indicates that patients with myocardial bridging may have more serious heart issues, including plaque buildup in their arteries, which could lead to chest pain and heart problems. Who this helps: This helps patients with myocardial bridging and their doctors understand potential risks and complications.

Plain English
This study examined the effect of a drug called terlipressin on the blood pressure in the lungs of patients with liver cirrhosis, particularly looking for improvements in a condition called portopulmonary hypertension. Out of 12 patients, the average lung artery pressure dropped from 25.5 mmHg to 22.5 mmHg after receiving terlipressin, which shows a significant improvement. Additionally, after treatment, four patients had their lung artery pressure reduced to a normal level, which helps address a critical complication of liver disease. Who this helps: This benefits patients with liver cirrhosis and their doctors by providing a potential treatment option for managing lung pressure issues.